OX40L targetted therapy(Psivant Therapeutics)

N/A

Report date: 2024/09/12 17:42:00
NME

Base Information

Drug NameOX40L targetted therapy(Psivant Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 4 stimulants
TargetsTumor necrosis factor ligand superfamily member 4
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPsivant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPsivant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A